Cited by 172Neuroinflammation and Neurodegeneration MechanismsPARP inhibition in cancer therapyAlzheimer's disease research and treatments

The role of PARP1 in neurodegenerative diseases and aging

Open access
Mao, Kanmin, Zhang, Guo·2022·The FEBS Journal

Abstract

Neurodegenerative diseases, including Alzheimer's disease (AD) and Parkinson's disease (PD), are characterized by progressive memory loss and motor impairment. Aging is a major risk factor for neurodegenerative diseases. Neurodegenerative diseases and aging often develop in an irreversible manner and cause a significant socioeconomic burden. When considering their pathogenesis, many studies usually focus on mitochondrial dysfunction and DNA damage. More recently, neuroinflammation, autophagy dysregulation, and SIRT1 inactivation were shown to be involved in the pathogenesis of neurodegenerative diseases and aging. In addition, studies uncovered the role of poly (ADP‐ribose)‐polymerase‐1 (PARP1) in neurodegenerative diseases and aging. PARP1 links to a cluster of stress signals, including those originated by inflammation and autophagy dysregulation. In this review, we summarized the recent research progresses on PARP1 in neurodegenerative diseases and aging, with an emphasis on the relationship among PARP1, neuroinflammation, mitochondria, and autophagy. We discussed the possibilities of treating neurodegenerative diseases and aging through targeting PARP1.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/febs.15716

Cites

113 of 113 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Increased PARP1 activation and elevated poly(ADP-ribose) are observed in numerous neurodegenerative disorders and their associated animal models.

    “Increased PARP1 activation and elevated poly(ADP‐ribose) has been observed in numerous neurodegenerative disorders and their associated animal models (Thapa et al, 2021; Mao & Zhang 2022).”

    From Mechanisms of DNA damage-mediated neurotoxicity in neurodegenerative disease (2022) · cites this paper as Mao & Zhang 2022

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Mao, K., & Zhang, G.
Affiliations
Huazhong University of Science and Technology (CN)
Corresponding author
Zhang, Guo
Venue
The FEBS Journal
Publisher
Wiley
Published
2021-02-08
Volume
289
Issue
8
Pages
2013-2024
ISSN
  • 1742-464X (ISSN-L)
  • 1742-4658
OpenAlex
W3125032790
Cited by
172
References
113
Citations by year
2026: 30 · 2025: 40 · 2024: 33 · 2023: 34 · 2022: 24 · 2021: 11
FWCI
2.98
Type
journal article
Language
en
Open access
Locations
  • FEBS Journal (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Natural Science Foundation of China (91539125, 81573146)
Topics
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
Keywords
PARP1, neurodegenerative diseases, aging, Alzheimer's disease, Parkinson's disease, neuroinflammation, autophagy dysregulation, mitochondrial dysfunction, SIRT1
MeSH terms
Poly (ADP-Ribose) Polymerase-1, Aging, Autophagy, Humans, Mitochondria, Neurodegenerative Diseases, Sirtuin 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review